Athos Therapeutics Inc

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)	Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, colitis, colonic disorder, digestive system disorder, gastroenteritis, immune system disorder, inflammatory bowel disease, intestinal disorder, ulcer disease, ulcerative colitis	Recruiting	Phase 2	2026-09-21		NCT07513181

Clinical trials